- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02986048
Proton Therapy Patient Registry
February 29, 2024 updated by: Case Comprehensive Cancer Center
The purpose of this study is to establish a database (or "registry") of patients treated with proton beam therapy at the University Hospitals (UH) Proton Therapy Center.
By keeping track of the patients treated it will allow the investigators to periodically evaluate the outcomes of patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this non-therapeutic registry study is to create a secure longitudinal database of patients treated with proton therapy at the UH Proton Therapy Center.
This will allow reporting patient, tumor, and treatment characteristics as well as outcome data pertaining to disease control and complications for this relatively rare radiation modality.
Study Type
Observational
Enrollment (Estimated)
999
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David B Mansur, MD
- Phone Number: 1-800-641-2422
- Email: CTUReferral@UHhospitals.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
-
Contact:
- David B Mansur, MD
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Principal Investigator:
- David B Mansur, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All patients treated with proton beam at the UH Proton Therapy Center
Description
Inclusion Criteria:
- Patients treated with proton beam at the UH Proton Therapy Center
- Patients who have the ability to understand and be willing to sign a written informed consent document
Exclusion Criteria:
- Patients or legal guardians who are unable to understand informed consent document
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Proton Beam Therapy
All patients treated with proton beam therapy at the UH Proton Therapy Center who consent to have their health information recorded, including whether the cancer was cured and if any complications occur ed due to treatment
|
Intervention is not assigned.
Only patient data is being collected
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of participants treated at UH Proton Therapy Center by proton beam therapy
Time Frame: Up to 10 years
|
Up to 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David B Mansur, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 22, 2016
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
December 6, 2016
First Submitted That Met QC Criteria
December 6, 2016
First Posted (Estimated)
December 8, 2016
Study Record Updates
Last Update Posted (Estimated)
March 4, 2024
Last Update Submitted That Met QC Criteria
February 29, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CASE4Y16
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment With Proton Beam Radiation Therapy
-
Guangzhou Concord Cancer CenterSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Varian, a Siemens...CompletedSolid Tumor | Proton Therapy | Radiation TherapyChina
-
EBG MedAustron GmbHRecruiting
-
Abramson Cancer Center at Penn MedicineRecruitingPatients With Pathologically Confirmed Neoplasia That Have Been | Selected for Definitive Photodynamic Therapy, Proton, or Photon Radiation TherapyUnited States
-
Massachusetts General HospitalRecruitingPediatric Patients Treated With Radiation TherapyUnited States
-
University Hospital, EssenRecruitingCervical Carcinoma | Radiation | Adaptive Radiotherapy | Image Guided Radiotherapy | Gynecological Tumor | Optimization | Curative Treatment | Adaptive Radiation TherapyGermany
-
Albert Einstein College of MedicineRecruitingSafety and Efficacy of Radiation Therapy for the Treatment of KeloidsUnited States
-
University of Wisconsin, MadisonSuspendedLiver Metastases | Stereotactic Body Radiation Therapy | MRI-guided TreatmentUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedWomen With Stage I or II Breast Cancer Undergoing Active Radiation TherapyUnited States
-
Novartis PharmaceuticalsCompletedProstate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSecond-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based TherapyChina
Clinical Trials on Proton Beam Therapy
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
Emory UniversityNational Cancer Institute (NCI)Not yet recruitingResectable Lung Non-Small Cell CarcinomaUnited States
-
Samsung Medical CenterCompletedLiver Neoplasm | Proton Therapy | Portal Vein Tumor ThrombosisKorea, Republic of
-
National Cancer Center, KoreaCompletedProstate AdenocarcinomaKorea, Republic of
-
Kantonsspital AarauUniversity Hospital, Zürich; Center for Proton Therapy, Paul Scherrer Institute...UnknownSoft Tissue SarcomaSwitzerland
-
University College, LondonUniversity of Sheffield; Asthma + Lung UK; Mesothelioma UKRecruitingMalignant Pleural MesotheliomaUnited Kingdom
-
M.D. Anderson Cancer CenterActive, not recruiting
-
Washington University School of MedicineTerminatedEsophageal Squamous Cell Carcinoma | Adenocarcinoma Of EsophagusUnited States
-
University of AarhusRecruitingAnal Cancer | Recurrent Anal CancerDenmark
-
University of WashingtonNational Cancer Institute (NCI)CompletedRecurrent Disease | Thoracic Neoplasm | Metastatic Malignant Neoplasm in the LungUnited States